Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Fulfaro

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Frontiers in Endocrinology|December 11, 2023
The role of bone modifying agents for secondary osteoporosis prevention and pain control in post-menopausal osteopenic breast cancer patients undergoing adjuvant aromatase inhibitorsAntonio Galvano, Valerio Gristina, Dalila Scaturro, et al.
Cancer Research|August 3, 2007
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancerFrancesco Dieli, David Vermijlen, Fabio Fulfaro, et al.
Cancer Chemotherapy and Pharmacology|July 26, 2005
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancerPierpaolo Correale, Fabio Fulfaro, Stefania Marsili, et al.
Therapeutic Advances in Medical Oncology|September 20, 2019
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysisAntonio Galvano, Simona Taverna, Giuseppe Badalamenti, et al.
Scientific Reports|September 27, 2024
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patientsValerio Gristina, Tancredi Didier Bazan Russo, Nadia Barraco, et al.
Cancers|March 1, 2020
Moving the Target on the Optimal Adjuvant Strategy for Resected Pancreatic Cancers: A Systematic Review with Meta-AnalysisAntonio Galvano, Marta Castiglia, Sergio Rizzo, et al.
Journal of Cellular Physiology|June 21, 2005
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinomaAntonio Russo, Simona Corsale, Valentina Agnese, et al.
Critical Reviews in Oncology/Hematology|January 3, 2023
Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visibleValerio Gristina, Maria La Mantia, Marta Peri, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Frontiers in Endocrinology|December 11, 2023
The role of bone modifying agents for secondary osteoporosis prevention and pain control in post-menopausal osteopenic breast cancer patients undergoing adjuvant aromatase inhibitorsAntonio Galvano, Valerio Gristina, Dalila Scaturro, et al.
Cancer Research|August 3, 2007
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancerFrancesco Dieli, David Vermijlen, Fabio Fulfaro, et al.
Cancer Chemotherapy and Pharmacology|July 26, 2005
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancerPierpaolo Correale, Fabio Fulfaro, Stefania Marsili, et al.
Therapeutic Advances in Medical Oncology|September 20, 2019
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysisAntonio Galvano, Simona Taverna, Giuseppe Badalamenti, et al.
Scientific Reports|September 27, 2024
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patientsValerio Gristina, Tancredi Didier Bazan Russo, Nadia Barraco, et al.
Cancers|March 1, 2020
Moving the Target on the Optimal Adjuvant Strategy for Resected Pancreatic Cancers: A Systematic Review with Meta-AnalysisAntonio Galvano, Marta Castiglia, Sergio Rizzo, et al.
Journal of Cellular Physiology|June 21, 2005
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinomaAntonio Russo, Simona Corsale, Valentina Agnese, et al.
Critical Reviews in Oncology/Hematology|January 3, 2023
Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visibleValerio Gristina, Maria La Mantia, Marta Peri, et al.
Pageof 4